Aortic aneurysm is a medical condition in which the aorta becomes enlarged. The abdominal aortic aneurysm and the thoracic aortic aneurysm are two types of aortic aneurysm. These conditions can cause abdominal pain, low blood pressure, loss of consciousness, and even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which is relatively safe and requires less time. However, not all patients with aneurysms are suitable for EVAR. In addition, it is difficult to treat aneurysms near or in the kidney with EVAR.
Get a Sample Copy of the Report 2021 @
The demand for minimally invasive surgery to treat various diseases has increased to promote the growth of the global endovascular aneurysm repair (EVAR) market. According to a 2016 study published in the New England Journal of Medicine, the number of patients who chose endovascular aneurysm repair increased significantly between 2005 and 2012. In 2005, the proportion of American aneurysm patients who chose EVAR was about 50%, and in 2012 it increased to 75.4%. A similar situation has occurred in the U.K.
Consumers are turning to this revolutionary surgery, which is credited as a minimally invasive treatment method that requires a minimal hospital stay, smaller incisions, fewer scars, and aids in quick recovery. This is expected to contribute to the growth of the global endovascular aneurysm repair (EVAR) market.
North America is expected to dominate the global endovascular aneurysm repair (EVAR) market during the forecast period. North America accounted for the largest share of the global endovascular aneurysm repair (EVAR) market in 2016 due to increasing prevalence of aneurysms and rising geriatric population. According to the New England Journal of Medicine, in 2016, between 2005 and 2012, 278,921 patients in the United States underwent abdominal aortic aneurysm repair. According to the Centers for Disease Control and Prevention (CDC), in 2014, aortic aneurysms caused 9,863 deaths in the U.S. In addition, aneurysms are more common in the elderly, that is, 50 years of age or older. According to the U.S. Population Reference Office, the population of 65 and over is expected to increase from 46 million in 2014 to more than 98 million in 2060. As the elderly population increases, the prevalence of aneurysms is expected to increase.
Ask for PDF sample copy of the report @
Europe is expected to become EVAR’s second largest market. This is due to the implementation of the National Health Service Plan across the U.K., which involves the detection of various diseases in people in the area. The successful implementation of this system in turn facilitated the rapid detection of abdominal aneurysms, especially in the UK, Italy and Sweden. This helps in the early diagnosis of the disease, thus increasing the demand for AAA treatments such as EVAR.
Major companies contributing in the global endovascular aneurysm repair (EVAR) market are Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Gore Medical, Cook Medical, Medtronic, St. Jude Medical Inc., Cordis Corporation, B. Braun Melsungen AG, Spectranetics International BV, C.R. Bard, and Volcano Corporation.
Reasons to Purchase this Report
• To gain an in-depth understanding of Endovascular Aneurysm Repair (EVAR) market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Endovascular Aneurysm Repair (EVAR) market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Buy This Complete A Business Report With Flat US $2000 Off @
Table of Content
Global Endovascular Aneurysm Repair (EVAR) Market Research Report
Section 1: Global Endovascular Aneurysm Repair (EVAR) Industry Overview
Section 2: Global Economic Impact on Endovascular Aneurysm Repair (EVAR) Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Endovascular Aneurysm Repair (EVAR) Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Endovascular Aneurysm Repair (EVAR) Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027